GAS1
Growth arrest-specific protein 1
Also known as: GAS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54826
- Gene
- GAS1
- Ensembl
- ENSG00000180447
- Chromosome
- 9
- Canonical length
- 345 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Growth arrest-specific 1 plays a role in growth suppression. GAS1 blocks entry to S phase and prevents cycling of normal and transformed cells. Gas1 is a putative tumor suppressor gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
345 residues, UniProt reviewed canonical sequence.
>P54826|GAS1
1 MVAALLGGGG EARGGTVPGA WLCLMALLQL LGSAPRGSGL AHGRRLICWQ ALLQCQGEPE
61 CSYAYNQYAE ACAPVLAQHG GGDAPGAAAA AFPASAASFS SRWRCPSHCI SALIQLNHTR
121 RGPALEDCDC AQDENCKSTK RAIEPCLPRT SGGGAGGPGA GGVMGCTEAR RRCDRDSRCN
181 LALSRYLTYC GKVFNGLRCT DECRTVIEDM LAMPKAALLN DCVCDGLERP ICESVKENMA
241 RLCFGAELGN GPGSSGSDGG LDDYYDEDYD DEQRTGGAGG EQPLDDDDGV PHPPRPGSGA
301 AASGGRGDLP YGPGRRSSGG GGRLAPRGAW TPLASILLLL LGPLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GAS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 81 nTPM
- adipose tissue: 69 nTPM
- fallopian tube: 52 nTPM
- smooth muscle: 41 nTPM
- ovary: 37 nTPM
- breast: 33 nTPM
Single-cell type
- decidual stromal cells: 272 nCPM
- fibroblasts: 166 nCPM
- mesothelial cells: 147 nCPM
- medullary thymic epithelial cells: 122 nCPM
- breast myoepithelial cells: 112 nCPM
- müller glia: 100 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 33 nTPM
- white matter: 13 nTPM
- basal ganglia: 8.2 nTPM
- cerebral cortex: 7.9 nTPM
- midbrain: 7 nTPM
- medulla oblongata: 6.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell fate commitment
- cellular response to vascular endothelial growth factor stimulus
- developmental growth
- negative regulation of mitotic cell cycle
- negative regulation of protein processing
- regulation of apoptotic process
- regulation of ER to Golgi vesicle-mediated transport
- regulation of smoothened signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GDNF/GAS1
- GDNF/GAS1 domain
- Growth arrest-specific protein 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GAS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GAS1 as an antibody target. Whether an autoantibody or antibody against GAS1 could matter depends on whether native GAS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GAS1 is annotated at the cell surface, where native GAS1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GAS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...